We are live on ! Find out more
FBRX icon

Forte Biosciences
FBRX

68 hedge funds and large institutions have $350M invested in Forte Biosciences in 2026 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

408% more call options, than puts

Call options by funds: $3.09M | Put options by funds: $609K

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

15.95% more ownership

Funds ownership: 91.99% → 107.94% (+16%)

15% more funds holding

Funds holding: 59 → 68 (+9)

11% more capital invested

Capital invested by funds: $315M → $350M (+$35.7M)

5% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 20

Holders
68
Holders Change
+9
Holders Change %
+15.25%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
19
Increased
21
Reduced
20
Closed
7
Calls
$3.09M
Puts
$609K
Net Calls
+$2.48M
Net Calls Change
+$2.46M

Top Buyers

Rank Fund Capital Flow
1
MB
MPM BioImpact
Massachusetts
+$28.8M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$17.8M
3
Morgan Stanley
Morgan Stanley
New York
+$12.4M
4
Citadel Advisors
Citadel Advisors
Florida
+$6.72M
5
IHAM
Integral Health Asset Management
New York
+$4.32M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$13.3M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$6.85M
3
FAM
Fred Alger Management
New York
-$5.39M
4
JG
Jain Global
New York
-$5.38M
5
IC
Ikarian Capital
Texas
-$5.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
26
Candriam SCA
Luxembourg
$2.2M +$2.44M +84,803 New
TI
27
Trexquant Investment
Connecticut
$1.91M +$1.75M +60,735 +470%
VFT
28
Vanguard Fiduciary Trust
Pennsylvania
$1.87M +$2.08M +72,095 New
BlackRock
29
BlackRock
New York
$1.71M +$41.1K +1,425 +2%
SC
30
Stempoint Capital
New York
$1.5M +$1.67M +58,020 New
Jane Street
31
Jane Street
New York
$1.5M +$1.43M +49,589 +594%
State Street
32
State Street
Massachusetts
$1.42M +$118K +4,100 +8%
JGC
33
J. Goldman & Co
New York
$1.4M -$191K -6,626 -11%
Goldman Sachs
34
Goldman Sachs
New York
$1.38M -$419K -14,550 -21%
Wellington Management Group
35
Wellington Management Group
Massachusetts
$764K +$850K +29,491 New
Envestnet Asset Management
36
Envestnet Asset Management
Illinois
$743K +$265K +9,199 +47%
MP
37
Mangrove Partners
Connecticut
$666K +$741K +25,706 New
WC
38
Weil Company
California
$641K +$713K +24,765 New
Northern Trust
39
Northern Trust
Illinois
$614K -$49.8K -1,729 -7%
Bank of America
40
Bank of America
North Carolina
$560K +$508K +17,634 +444%
Squarepoint
41
Squarepoint
New York
$538K +$598K +20,755 New
UBS Group
42
UBS Group
Switzerland
$530K -$126K -4,374 -18%
6CM
43
683 Capital Management
New York
$518K -$576K -20,000 -50%
Hudson Bay Capital Management
44
Hudson Bay Capital Management
Connecticut
$494K +$73.2K +2,541 +15%
Balyasny Asset Management
45
Balyasny Asset Management
Illinois
$485K +$539K +18,717 New
QC
46
Quadrature Capital
United Kingdom
$482K +$30.2K +1,049 +6%
EGM
47
Engineers Gate Manager
New York
$425K +$473K +16,427 New
JG
48
Jain Global
New York
$404K -$5.38M -186,836 -92%
Two Sigma Investments
49
Two Sigma Investments
New York
$402K -$470K -16,299 -51%
BHCM
50
Brevan Howard Capital Management
Jersey
$363K +$404K +14,020 New
1
2
3

FBRX Hedge Fund Activity: Q1 2026 in Review

68 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q1 2026, worth a combined $350M — up 11% from $315M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new FBRX positions and 7 closed out — a net gain of 12 holders — while 21 added to existing stakes and 20 trimmed.

The largest buyer was MPM BioImpact, opening a new position worth an estimated $28.8M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $13.3M sold.

  • 68 institutional investors held Forte Biosciences (FBRX) as of Q1 2026, up from 59 in Q4 2025.
  • Funds reported $350M of Forte Biosciences stock for Q1 2026, up 11% quarter-over-quarter.
  • 19 funds opened new Forte Biosciences positions in Q1 2026 and 7 closed out, a net change of +12 holders.
  • The largest Forte Biosciences buyer in Q1 2026 was MPM BioImpact, an estimated $28.8M added.
  • The largest Forte Biosciences seller in Q1 2026 was Point72 Asset Management, an estimated $13.3M sold.

Based on aggregated 13F filings for Q1 2026.